The National Inpatient Diabetes COVID-19 Response Group has put together a series of guidance in response to the coronavirus pandemic.
The group was set up at the beginning of the crisis and is chaired by Professor Gerry Rayman MBE, realising five guidelines and supporting information to aid healthcare professionals.
The clinical guidance has been pulled together with insight from clinical leads across UK centres which have so far gathered the greatest experience of looking after people with diabetes and COVID-19.
Guidance documents
- COncise adVice on Inpatient Diabetes (COVID:Diabetes): Dexamethasone Therapy in COVID-19 Patients: Implications and Guidance for the Management of Blood Glucose in People with and Without Diabetes
- ‘COncise adVice on Inpatient Diabetes (COVID Diabetes) Safe and supported discharge to reduce readmissions and improve patient flow’
- COncise adVice on Inpatient Diabetes (COVID:Diabetes): Guidance for managing inpatient hyperglycaemia
- COncise adVice on Inpatient Diabetes (COVID:Diabetes): Guideline for managing DKA using subcutaneous insulin
- COncise adVice on Inpatient Diabetes (COVID:Diabetes) – Front Door Guidance
- View a letter from the team highlighting the need to maintain patient safety whilst accelerating patient flow through the system, including preventing avoidable admissions and readmissions.
- Maintaining acute diabetes services in response to COVID-19
- Speciality template for acute diabetes services
